Bausch Health Companies Inc.
BHC· NYSE
BHCBausch Health Companies Inc.
Filed Feb 23, 2023 · 10-K · 54 days after period end · 0000885590-23-000009
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $2.19B | $2.20B | $2.21B | $2.22B |
| Net Income | -$410.00M | $69.00M | -$153.00M | -$1.52B |
| EPS Diluted | — | — | -$0.43 | -$4.30 |
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 23, 2023 · 54 d after period end
